GlassScriptPhysician profile
Eric K Fanaee
NPI 1184945305
$18,410.80
in general payments reported to CMS, 2019-2025
16 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $886 · 2020: $240 · 2021: $1,471 · 2022: $11K · 2023: $3,477 · 2024: $514 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,304 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,350 · Travel and Lodging: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,303.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,350.00 |
| Travel and Lodging | $872.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $15,420.10 | 2020-2023 | Intracept |
| Boston Scientific Corporation | $817.62 | 2022-2025 | Intracept |
| Medtronic USA, INC. | $762.21 | 2019-2020 | |
| Medtronic, INC. | $466.45 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbott Laboratories | $398.93 | 2019-2023 | Proclaim |
| Spineology INC. | $111.61 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $85.84 | 2022-2023 | Seglentis |
| Collegium Pharmaceutical, INC. | $79.09 | 2020-2023 | Belbuca |
| Stryker Corporation | $61.03 | 2023 | Ivas, Autoplex |
| Nevro Corp. | $53.20 | 2021-2022 | |
| Curonix LLC | $49.52 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $23.30 | 2019 | |
| Scilex Pharmaceuticals INC. | $23.04 | 2023 | Ztlido |
| Avanos Medical | $22.55 | 2021 | |
| Averitas Pharma INC. | $22.51 | 2025 | Qutenza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fanaee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.